跳至主要内容
临床试验/CTRI/2025/06/088225
CTRI/2025/06/088225尚未招募2/3 期

A randomised control trial to evaluate the effect of Laaja Saktu in the management of Urdhwaga Amlapitta.

Sane guruji Arogya Kendra1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年6月10日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
入组人数
60
试验地点
1
主要终点
To study the effect of lajasaktu in the management of Urdhwag Amlapitta.

研究概览

简要总结

The parameters of efficacy of lajasaktu will be evaluated by observing patients through subjective criteria at regular intervals 0th,7th, 14th days follow up. The relief of sign and symptoms of Amlapitta will be evaluated with the help of questionnaire.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
19.00 Year(s) 至 40.00 Year(s)(—)
性别
All

入选标准

  • Recently diagnosed patients with Urdhwag Amlapitta.

排除标准

  • Diabetic patients Patients with severe vomiting and diarrhea Chronic disease like HIV, Tuberculosis and gastric ulcer Pregnant and lactating mothers Patients with drug induced hyperactivity.

结局指标

主要结局

To study the effect of lajasaktu in the management of Urdhwag Amlapitta.

时间窗: The parameters of efficacy of lajasaktu will be evaluated by observing patients through subjective criteria at regular intervals 0th,7th, 14th days follow up. The relief of sign and symptoms of Amlapitta will be evaluated with the help of questionnaire.

次要结局

  • To prepare and standardize lajasaktu. To study effect of lajasaktu on Amlapitta.(The parameters of efficacy of lajasaktu will be evaluated by observing patients through subjective criteria at regular intervals 0th,7th, 14th days follow up. The relief of sign and symptoms of Amlapitta will be evaluated with the help of questionnaire.)

研究者

申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Dr Snehal Satish Aher

MAMs Sumatibhai Shah Ayurved Mahavidyalay, Hadapsar

研究点 (1)

Loading locations...

相似试验